Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2020-06-29
2020-08-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Projected Peripheral Defocus on Ocular Biometrics
NCT04388020
Binocular Peripheral Myopic Defocus Using a Clinical Prototype Device
NCT05425108
Electronic Spectacles Versus Low Dose Atropine in Young Myopes
NCT06034379
3D Designed Defocus Lenses on Myopia Control in Children and Adolescents
NCT07284147
Eye Length Signal With Myopia Control
NCT04813640
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test Arm
Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.)
For the right/test eye, a defocused image is projected onto the peripheral retina while the subject views a distant, in-focus image
No Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.)
For the left/control eye, no image is projected onto the peripheral retina. The subject views a distant, in-focus image.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.)
For the right/test eye, a defocused image is projected onto the peripheral retina while the subject views a distant, in-focus image
No Active projection of defocused image in the peripheral visual field (eSpecs, Acucela Inc.)
For the left/control eye, no image is projected onto the peripheral retina. The subject views a distant, in-focus image.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Refractive cylinder ≤ 0.75 diopters
* Visual acuity 20/20 -3 or better
Exclusion Criteria
* Active ocular infection
* History of dry eye, strabismus, or amblyopia
* Previous or planned ocular surgery
* Use of medication known to affect vision or accommodation
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kubota Vision Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arkady Selenow, OD
Role: PRINCIPAL_INVESTIGATOR
Manhattan Vision Associates/Institute of Vision Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Manhattan Vision Associates/institute of Vision Research
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
eSpec Phase III
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.